Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Market IntelliX Research, the global market for Eukaryotic Transcriptome Sequencing should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
China Eukaryotic Transcriptome Sequencing market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
The United States Eukaryotic Transcriptome Sequencing market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
In terms of type, Total RNA segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Biomedical Field has a share approximately % in 2023 and will grow at a CAGR % during 2024 and 2030.
The global key manufacturers of Eukaryotic Transcriptome Sequencing include Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Roche, Pacific Biosciences, Eurofins Scientific and Azenta, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Eukaryotic Transcriptome Sequencing. Report Highlights:
(1) Global Eukaryotic Transcriptome Sequencing market size (value),history data from 2019-2024 and forecast data from 2024 to 2030.
(2) Global Eukaryotic Transcriptome Sequencing market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Eukaryotic Transcriptome Sequencing market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Eukaryotic Transcriptome Sequencing segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Eukaryotic Transcriptome Sequencing segment by type and by application and regional segment by type and by application.
(6) Eukaryotic Transcriptome Sequencing industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Total RNA
Noncoding RNA
Market segment by application, can be divided into
Biomedical Field
Non-medical Field
Market segment by players, this report covers
Illumina
Thermo Fisher Scientific
Bio-Rad
Agilent Technologies
QIAGEN
Roche
Pacific Biosciences
Eurofins Scientific
Azenta
LabCorp
BGI Genomics
Zhijiang Biology
Novogene Co., Ltd
Macrogen
Tsingke Biotechnology Co., Ltd.
1 Market Overview
1.1 Product Overview and Scope of Eukaryotic Transcriptome Sequencing
1.2 Global Eukaryotic Transcriptome Sequencing Market Size and Forecast
1.3 China Eukaryotic Transcriptome Sequencing Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Eukaryotic Transcriptome Sequencing Share in Global Market, 2019-2030
1.4.2 Eukaryotic Transcriptome Sequencing Market Size: China VS Global, 2019-2030
1.5 Eukaryotic Transcriptome Sequencing Market Dynamics
1.5.1 Eukaryotic Transcriptome Sequencing Market Drivers
1.5.2 Eukaryotic Transcriptome Sequencing Market Restraints
1.5.3 Eukaryotic Transcriptome Sequencing Industry Trends
1.5.4 Eukaryotic Transcriptome Sequencing Industry Policy
2 Global Competitive Situation by Company
2.1 Global Eukaryotic Transcriptome Sequencing Revenue by Company (2019-2024)
2.2 Global Eukaryotic Transcriptome Sequencing Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Eukaryotic Transcriptome Sequencing Concentration Ratio
2.4 Global Eukaryotic Transcriptome Sequencing Mergers & Acquisitions, Expansion Plans
2.5 Global Eukaryotic Transcriptome Sequencing Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Eukaryotic Transcriptome Sequencing Revenue by Company (2019-2024)
3.2 China Eukaryotic Transcriptome Sequencing Eukaryotic Transcriptome Sequencing Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Eukaryotic Transcriptome Sequencing, Revenue Percentage of Local Players VS Foreign Manufacturers (2019-2024)
4 Industry Chain Analysis
4.1 Eukaryotic Transcriptome Sequencing Industry Chain
4.2 Eukaryotic Transcriptome Sequencing Upstream Analysis
4.3 Eukaryotic Transcriptome Sequencing Midstream Analysis
4.4 Eukaryotic Transcriptome Sequencing Downstream Analysis
5 Sights by Type
5.1 Eukaryotic Transcriptome Sequencing Classification
5.1.1 Total RNA
5.1.2 Noncoding RNA
5.2 By Type, Global Eukaryotic Transcriptome Sequencing Market Size & CAGR, 2019 VS 2024 VS 2030
5.3 By Type, Global Eukaryotic Transcriptome Sequencing Revenue, 2019-2030
6 Sights by Application
6.1 Eukaryotic Transcriptome Sequencing Segment by Application
6.1.1 Biomedical Field
6.1.2 Non-medical Field
6.2 By Application, Global Eukaryotic Transcriptome Sequencing Market Size & CAGR, 2019 VS 2024 VS 2030
6.3 By Application, Global Eukaryotic Transcriptome Sequencing Revenue, 2019-2030
7 Sales Sights by Region
7.1 By Region, Global Eukaryotic Transcriptome Sequencing Market Size, 2019 VS 2024 VS 2030
7.2 By Region, Global Eukaryotic Transcriptome Sequencing Market Size, 2019-2030
7.3 North America
7.3.1 North America Eukaryotic Transcriptome Sequencing Market Size & Forecasts, 2019-2030
7.3.2 By Country, North America Eukaryotic Transcriptome Sequencing Market Size Market Share
7.4 Europe
7.4.1 Europe Eukaryotic Transcriptome Sequencing Market Size & Forecasts, 2019-2030
7.4.2 By Country, Europe Eukaryotic Transcriptome Sequencing Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Eukaryotic Transcriptome Sequencing Market Size & Forecasts, 2019-2030
7.5.2 By Country/Region, Asia Pacific Eukaryotic Transcriptome Sequencing Market Size Market Share
7.6 South America
7.6.1 South America Eukaryotic Transcriptome Sequencing Market Size & Forecasts, 2019-2030
7.6.2 By Country, South America Eukaryotic Transcriptome Sequencing Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Eukaryotic Transcriptome Sequencing Market Size & CAGR,2019 VS 2024 VS 2030
8.2 By Country, Global Eukaryotic Transcriptome Sequencing Market Size, 2019-2030
8.3 U.S.
8.3.1 U.S. Eukaryotic Transcriptome Sequencing Market Size, 2019-2030
8.3.2 By Company, U.S. Eukaryotic Transcriptome Sequencing Revenue Market Share, 2019-2024
8.3.3 By Type, U.S. Eukaryotic Transcriptome Sequencing Revenue Market Share, 2023 VS 2030
8.3.4 By Application, U.S. Eukaryotic Transcriptome Sequencing Revenue Market Share, 2023 VS 2030
8.4 Europe
8.4.1 Europe Eukaryotic Transcriptome Sequencing Market Size, 2019-2030
8.4.2 By Company, Europe Eukaryotic Transcriptome Sequencing Revenue Market Share, 2019-2024
8.4.3 By Type, Europe Eukaryotic Transcriptome Sequencing Revenue Market Share, 2023 VS 2030
8.4.4 By Application, Europe Eukaryotic Transcriptome Sequencing Revenue Market Share, 2023 VS 2030
8.5 China
8.5.1 China Eukaryotic Transcriptome Sequencing Market Size, 2019-2030
8.5.2 By Company, China Eukaryotic Transcriptome Sequencing Revenue Market Share, 2019-2024
8.5.3 By Type, China Eukaryotic Transcriptome Sequencing Revenue Market Share, 2023 VS 2030
8.5.4 By Application, China Eukaryotic Transcriptome Sequencing Revenue Market Share, 2023 VS 2030
8.6 Japan
8.6.1 Japan Eukaryotic Transcriptome Sequencing Market Size, 2019-2030
8.6.2 By Company, Japan Eukaryotic Transcriptome Sequencing Revenue Market Share, 2019-2024
8.6.3 By Type, Japan Eukaryotic Transcriptome Sequencing Revenue Market Share, 2023 VS 2030
8.6.4 By Application, Japan Eukaryotic Transcriptome Sequencing Revenue Market Share, 2023 VS 2030
8.7 South Korea
8.7.1 South Korea Eukaryotic Transcriptome Sequencing Market Size, 2019-2030
8.7.2 By Company, South Korea Eukaryotic Transcriptome Sequencing Revenue Market Share, 2019-2024
8.7.3 By Type, South Korea Eukaryotic Transcriptome Sequencing Revenue Market Share, 2023 VS 2030
8.7.4 By Application, South Korea Eukaryotic Transcriptome Sequencing Revenue Market Share, 2023 VS 2030
8.8 Southeast Asia
8.8.1 Southeast Asia Eukaryotic Transcriptome Sequencing Market Size, 2019-2030
8.8.2 By Company, Southeast Asia Eukaryotic Transcriptome Sequencing Revenue Market Share, 2019-2024
8.8.3 By Type, Southeast Asia Eukaryotic Transcriptome Sequencing Revenue Market Share, 2023 VS 2030
8.8.4 By Application, Southeast Asia Eukaryotic Transcriptome Sequencing Revenue Market Share, 2023 VS 2030
8.9 India
8.9.1 India Eukaryotic Transcriptome Sequencing Market Size, 2019-2030
8.9.2 By Company, India Eukaryotic Transcriptome Sequencing Revenue Market Share, 2019-2024
8.9.3 By Type, India Eukaryotic Transcriptome Sequencing Revenue Market Share, 2023 VS 2030
8.9.4 By Application, India Eukaryotic Transcriptome Sequencing Revenue Market Share, 2023 VS 2030
8.10 Middle East & Asia
8.10.1 Middle East & Asia Eukaryotic Transcriptome Sequencing Market Size, 2019-2030
8.10.2 By Company, Middle East & Asia Eukaryotic Transcriptome Sequencing Revenue Market Share, 2019-2024
8.10.3 By Type, Middle East & Asia Eukaryotic Transcriptome Sequencing Revenue Market Share, 2023 VS 2030
8.10.4 By Application, Middle East & Asia Eukaryotic Transcriptome Sequencing Revenue Market Share, 2023 VS 2030
9 Global Manufacturers Profile
9.1 Illumina
9.1.1 Illumina Company Information, Head Office, Market Area and Industry Position
9.1.2 Illumina Company Profile and Main Business
9.1.3 Illumina Eukaryotic Transcriptome Sequencing Models, Specifications and Application
9.1.4 Illumina Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
9.1.5 Illumina Recent Developments
9.2 Thermo Fisher Scientific
9.2.1 Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
9.2.2 Thermo Fisher Scientific Company Profile and Main Business
9.2.3 Thermo Fisher Scientific Eukaryotic Transcriptome Sequencing Models, Specifications and Application
9.2.4 Thermo Fisher Scientific Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
9.2.5 Thermo Fisher Scientific Recent Developments
9.3 Bio-Rad
9.3.1 Bio-Rad Company Information, Head Office, Market Area and Industry Position
9.3.2 Bio-Rad Company Profile and Main Business
9.3.3 Bio-Rad Eukaryotic Transcriptome Sequencing Models, Specifications and Application
9.3.4 Bio-Rad Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
9.3.5 Bio-Rad Recent Developments
9.4 Agilent Technologies
9.4.1 Agilent Technologies Company Information, Head Office, Market Area and Industry Position
9.4.2 Agilent Technologies Company Profile and Main Business
9.4.3 Agilent Technologies Eukaryotic Transcriptome Sequencing Models, Specifications and Application
9.4.4 Agilent Technologies Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
9.4.5 Agilent Technologies Recent Developments
9.5 QIAGEN
9.5.1 QIAGEN Company Information, Head Office, Market Area and Industry Position
9.5.2 QIAGEN Company Profile and Main Business
9.5.3 QIAGEN Eukaryotic Transcriptome Sequencing Models, Specifications and Application
9.5.4 QIAGEN Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
9.5.5 QIAGEN Recent Developments
9.6 Roche
9.6.1 Roche Company Information, Head Office, Market Area and Industry Position
9.6.2 Roche Company Profile and Main Business
9.6.3 Roche Eukaryotic Transcriptome Sequencing Models, Specifications and Application
9.6.4 Roche Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
9.6.5 Roche Recent Developments
9.7 Pacific Biosciences
9.7.1 Pacific Biosciences Company Information, Head Office, Market Area and Industry Position
9.7.2 Pacific Biosciences Company Profile and Main Business
9.7.3 Pacific Biosciences Eukaryotic Transcriptome Sequencing Models, Specifications and Application
9.7.4 Pacific Biosciences Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
9.7.5 Pacific Biosciences Recent Developments
9.8 Eurofins Scientific
9.8.1 Eurofins Scientific Company Information, Head Office, Market Area and Industry Position
9.8.2 Eurofins Scientific Company Profile and Main Business
9.8.3 Eurofins Scientific Eukaryotic Transcriptome Sequencing Models, Specifications and Application
9.8.4 Eurofins Scientific Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
9.8.5 Eurofins Scientific Recent Developments
9.9 Azenta
9.9.1 Azenta Company Information, Head Office, Market Area and Industry Position
9.9.2 Azenta Company Profile and Main Business
9.9.3 Azenta Eukaryotic Transcriptome Sequencing Models, Specifications and Application
9.9.4 Azenta Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
9.9.5 Azenta Recent Developments
9.10 LabCorp
9.10.1 LabCorp Company Information, Head Office, Market Area and Industry Position
9.10.2 LabCorp Company Profile and Main Business
9.10.3 LabCorp Eukaryotic Transcriptome Sequencing Models, Specifications and Application
9.10.4 LabCorp Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
9.10.5 LabCorp Recent Developments
9.11 BGI Genomics
9.11.1 BGI Genomics Company Information, Head Office, Market Area and Industry Position
9.11.2 BGI Genomics Company Profile and Main Business
9.11.3 BGI Genomics Eukaryotic Transcriptome Sequencing Models, Specifications and Application
9.11.4 BGI Genomics Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
9.11.5 BGI Genomics Recent Developments
9.12 Zhijiang Biology
9.12.1 Zhijiang Biology Company Information, Head Office, Market Area and Industry Position
9.12.2 Zhijiang Biology Company Profile and Main Business
9.12.3 Zhijiang Biology Eukaryotic Transcriptome Sequencing Models, Specifications and Application
9.12.4 Zhijiang Biology Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
9.12.5 Zhijiang Biology Recent Developments
9.13 Novogene Co., Ltd
9.13.1 Novogene Co., Ltd Company Information, Head Office, Market Area and Industry Position
9.13.2 Novogene Co., Ltd Company Profile and Main Business
9.13.3 Novogene Co., Ltd Eukaryotic Transcriptome Sequencing Models, Specifications and Application
9.13.4 Novogene Co., Ltd Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
9.13.5 Novogene Co., Ltd Recent Developments
9.14 Macrogen
9.14.1 Macrogen Company Information, Head Office, Market Area and Industry Position
9.14.2 Macrogen Company Profile and Main Business
9.14.3 Macrogen Eukaryotic Transcriptome Sequencing Models, Specifications and Application
9.14.4 Macrogen Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
9.14.5 Macrogen Recent Developments
9.15 Tsingke Biotechnology Co., Ltd.
9.15.1 Tsingke Biotechnology Co., Ltd. Company Information, Head Office, Market Area and Industry Position
9.15.2 Tsingke Biotechnology Co., Ltd. Company Profile and Main Business
9.15.3 Tsingke Biotechnology Co., Ltd. Eukaryotic Transcriptome Sequencing Models, Specifications and Application
9.15.4 Tsingke Biotechnology Co., Ltd. Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
9.15.5 Tsingke Biotechnology Co., Ltd. Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables & Figures:
Table 1. Eukaryotic Transcriptome Sequencing Market Size & CAGR: China VS Global, (US$ Million), 2019-2030
Table 2. Eukaryotic Transcriptome Sequencing Market Restraints
Table 3. Eukaryotic Transcriptome Sequencing Market Trends
Table 4. Eukaryotic Transcriptome Sequencing Industry Policy
Table 5. Global Eukaryotic Transcriptome Sequencing Revenue by Company (2019-2024) & (US$ million)
Table 6. Global Eukaryotic Transcriptome Sequencing Revenue Market Share by Company (2019-2024)
Table 7. Global Eukaryotic Transcriptome Sequencing Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Eukaryotic Transcriptome Sequencing Mergers & Acquisitions, Expansion Plans
Table 9. Global Eukaryotic Transcriptome Sequencing Manufacturers Product Type
Table 10. China Eukaryotic Transcriptome Sequencing Revenue by Company (2019-2024) & (US$ million)
Table 11. China Eukaryotic Transcriptome Sequencing Revenue Market Share by Company (2019-2024)
Table 12. Global Key Players of Eukaryotic Transcriptome Sequencing Upstream (Raw Materials)
Table 13. Global Eukaryotic Transcriptome Sequencing Typical Customers
Table 14. Eukaryotic Transcriptome Sequencing Typical Distributors
Table 15. By Type, Global Eukaryotic Transcriptome Sequencing Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 16. By Application, Global Eukaryotic Transcriptome Sequencing Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 17. By Region, Global Eukaryotic Transcriptome Sequencing Market Size, 2019 VS 2024 VS 2030, US$ Million
Table 18. By Region, Global Eukaryotic Transcriptome Sequencing Revenue, 2019-2030, US$ Million
Table 19. By Country, Global Eukaryotic Transcriptome Sequencing Revenue & CAGR,2019 VS 2024 VS 2030, US$ Million
Table 20. By Country, Global Eukaryotic Transcriptome Sequencing Revenue, 2019-2030, US$ Million
Table 21. By Country, Global Eukaryotic Transcriptome Sequencing Revenue Market Share, 2019-2030
Table 22. Illumina Company Information, Head Office, Market Area and Industry Position
Table 23. Illumina Company Profile and Main Business
Table 24. Illumina Eukaryotic Transcriptome Sequencing Models, Specifications and Application
Table 25. Illumina Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
Table 26. Illumina Recent Developments
Table 27. Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
Table 28. Thermo Fisher Scientific Company Profile and Main Business
Table 29. Thermo Fisher Scientific Eukaryotic Transcriptome Sequencing Models, Specifications and Application
Table 30. Thermo Fisher Scientific Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
Table 31. Thermo Fisher Scientific Recent Developments
Table 32. Bio-Rad Company Information, Head Office, Market Area and Industry Position
Table 33. Bio-Rad Company Profile and Main Business
Table 34. Bio-Rad Eukaryotic Transcriptome Sequencing Models, Specifications and Application
Table 35. Bio-Rad Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
Table 36. Bio-Rad Recent Developments
Table 37. Agilent Technologies Company Information, Head Office, Market Area and Industry Position
Table 38. Agilent Technologies Company Profile and Main Business
Table 39. Agilent Technologies Eukaryotic Transcriptome Sequencing Models, Specifications and Application
Table 40. Agilent Technologies Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
Table 41. Agilent Technologies Recent Developments
Table 42. QIAGEN Company Information, Head Office, Market Area and Industry Position
Table 43. QIAGEN Company Profile and Main Business
Table 44. QIAGEN Eukaryotic Transcriptome Sequencing Models, Specifications and Application
Table 45. QIAGEN Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
Table 46. QIAGEN Recent Developments
Table 47. Roche Company Information, Head Office, Market Area and Industry Position
Table 48. Roche Company Profile and Main Business
Table 49. Roche Eukaryotic Transcriptome Sequencing Models, Specifications and Application
Table 50. Roche Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
Table 51. Roche Recent Developments
Table 52. Pacific Biosciences Company Information, Head Office, Market Area and Industry Position
Table 53. Pacific Biosciences Company Profile and Main Business
Table 54. Pacific Biosciences Eukaryotic Transcriptome Sequencing Models, Specifications and Application
Table 55. Pacific Biosciences Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
Table 56. Pacific Biosciences Recent Developments
Table 57. Eurofins Scientific Company Information, Head Office, Market Area and Industry Position
Table 58. Eurofins Scientific Company Profile and Main Business
Table 59. Eurofins Scientific Eukaryotic Transcriptome Sequencing Models, Specifications and Application
Table 60. Eurofins Scientific Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
Table 61. Eurofins Scientific Recent Developments
Table 62. Azenta Company Information, Head Office, Market Area and Industry Position
Table 63. Azenta Company Profile and Main Business
Table 64. Azenta Eukaryotic Transcriptome Sequencing Models, Specifications and Application
Table 65. Azenta Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
Table 66. Azenta Recent Developments
Table 67. LabCorp Company Information, Head Office, Market Area and Industry Position
Table 68. LabCorp Company Profile and Main Business
Table 69. LabCorp Eukaryotic Transcriptome Sequencing Models, Specifications and Application
Table 70. LabCorp Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
Table 71. LabCorp Recent Developments
Table 72. BGI Genomics Company Information, Head Office, Market Area and Industry Position
Table 73. BGI Genomics Company Profile and Main Business
Table 74. BGI Genomics Eukaryotic Transcriptome Sequencing Models, Specifications and Application
Table 75. BGI Genomics Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
Table 76. BGI Genomics Recent Developments
Table 77. Zhijiang Biology Company Information, Head Office, Market Area and Industry Position
Table 78. Zhijiang Biology Company Profile and Main Business
Table 79. Zhijiang Biology Eukaryotic Transcriptome Sequencing Models, Specifications and Application
Table 80. Zhijiang Biology Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
Table 81. Zhijiang Biology Recent Developments
Table 82. Novogene Co., Ltd Company Information, Head Office, Market Area and Industry Position
Table 83. Novogene Co., Ltd Company Profile and Main Business
Table 84. Novogene Co., Ltd Eukaryotic Transcriptome Sequencing Models, Specifications and Application
Table 85. Novogene Co., Ltd Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
Table 86. Novogene Co., Ltd Recent Developments
Table 87. Macrogen Company Information, Head Office, Market Area and Industry Position
Table 88. Macrogen Company Profile and Main Business
Table 89. Macrogen Eukaryotic Transcriptome Sequencing Models, Specifications and Application
Table 90. Macrogen Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
Table 91. Macrogen Recent Developments
Table 92. Tsingke Biotechnology Co., Ltd. Company Information, Head Office, Market Area and Industry Position
Table 93. Tsingke Biotechnology Co., Ltd. Company Profile and Main Business
Table 94. Tsingke Biotechnology Co., Ltd. Eukaryotic Transcriptome Sequencing Models, Specifications and Application
Table 95. Tsingke Biotechnology Co., Ltd. Eukaryotic Transcriptome Sequencing Revenue and Gross Margin, 2019-2024
Table 96. Tsingke Biotechnology Co., Ltd. Recent Developments
List of Figure
Figure 1. Eukaryotic Transcriptome Sequencing Picture
Figure 2. Global Eukaryotic Transcriptome Sequencing Industry Market Size and Forecast (US$ million) & (2019-2030)
Figure 3. China Eukaryotic Transcriptome Sequencing Revenue and Forecast (US$ million) & (2019-2030)
Figure 4. 2019-2030 China Eukaryotic Transcriptome Sequencing Market Share of Global
Figure 5. Global Eukaryotic Transcriptome Sequencing Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Eukaryotic Transcriptome Sequencing Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2019-2024
Figure 7. China Eukaryotic Transcriptome Sequencing Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Eukaryotic Transcriptome Sequencing Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024
Figure 9. Eukaryotic Transcriptome Sequencing Industry Chain
Figure 10. Total RNA
Figure 11. Noncoding RNA
Figure 12. By Type, Global Eukaryotic Transcriptome Sequencing Revenue, 2019-2030, US$ Million
Figure 13. By Type, Global Eukaryotic Transcriptome Sequencing Revenue Market Share, 2019-2030
Figure 14. Biomedical Field
Figure 15. Non-medical Field
Figure 16. By Application, Global Eukaryotic Transcriptome Sequencing Revenue, 2019-2030, US$ Million
Figure 17. By Application, Global Eukaryotic Transcriptome Sequencing Revenue Market Share, 2019-2030
Figure 18. By Region, Global Eukaryotic Transcriptome Sequencing Revenue Market Share, 2019-2030
Figure 19. North America Eukaryotic Transcriptome Sequencing Revenue & Forecasts, 2019-2030, US$ Million
Figure 20. By Country, North America Eukaryotic Transcriptome Sequencing Revenue Market Share, 2019-2024
Figure 21. Europe Eukaryotic Transcriptome Sequencing Revenue & Forecasts, 2019-2030, US$ Million
Figure 22. By Country, Europe Eukaryotic Transcriptome Sequencing Revenue Market Share, 2019-2024
Figure 23. Asia Pacific Eukaryotic Transcriptome Sequencing Revenue & Forecasts, 2019-2030, US$ Million
Figure 24. By Country/Region, Asia Pacific Eukaryotic Transcriptome Sequencing Revenue Market Share, 2019-2024
Figure 25. South America Eukaryotic Transcriptome Sequencing Revenue & Forecasts, 2019-2030, US$ Million
Figure 26. By Country, South America Eukaryotic Transcriptome Sequencing Revenue Market Share, 2019-2024
Figure 27. Middle East & Africa Eukaryotic Transcriptome Sequencing Revenue & Forecasts, 2019-2030, US$ Million
Figure 28. U.S. Eukaryotic Transcriptome Sequencing Revenue, 2019-2030, (US$ Million)
Figure 29. By Company, U.S. Eukaryotic Transcriptome Sequencing Market Share, 2019-2024
Figure 30. By Type, U.S. Eukaryotic Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 31. By Application, U.S. Eukaryotic Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 32. Europe Eukaryotic Transcriptome Sequencing Revenue, 2019-2030, (US$ Million)
Figure 33. By Company, Europe Eukaryotic Transcriptome Sequencing Market Share, 2019-2024
Figure 34. By Type, Europe Eukaryotic Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 35. By Application, Europe Eukaryotic Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 36. China Eukaryotic Transcriptome Sequencing Revenue, 2019-2030, (US$ Million)
Figure 37. By Company, China Eukaryotic Transcriptome Sequencing Market Share, 2019-2024
Figure 38. By Type, China Eukaryotic Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 39. By Application, China Eukaryotic Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 40. Japan Eukaryotic Transcriptome Sequencing Revenue, 2019-2030, (US$ Million)
Figure 41. By Company, Japan Eukaryotic Transcriptome Sequencing Market Share, 2019-2024
Figure 42. By Type, Japan Eukaryotic Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 43. By Application, Japan Eukaryotic Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 44. South Korea Eukaryotic Transcriptome Sequencing Revenue, 2019-2030, (US$ Million)
Figure 45. By Company, South Korea Eukaryotic Transcriptome Sequencing Market Share, 2019-2024
Figure 46. By Type, South Korea Eukaryotic Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 47. By Application, South Korea Eukaryotic Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 48. Southeast Asia Eukaryotic Transcriptome Sequencing Revenue, 2019-2030, (US$ Million)
Figure 49. By Company, Southeast Asia Eukaryotic Transcriptome Sequencing Market Share, 2019-2024
Figure 50. By Type, Southeast Asia Eukaryotic Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 51. By Application, Southeast Asia Eukaryotic Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 52. India Eukaryotic Transcriptome Sequencing Revenue, 2019-2030, (US$ Million)
Figure 53. By Company, India Eukaryotic Transcriptome Sequencing Market Share, 2019-2024
Figure 54. By Type, India Eukaryotic Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 55. By Application, India Eukaryotic Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 56. Middle East & Asia Eukaryotic Transcriptome Sequencing Revenue, 2019-2030, (US$ Million)
Figure 57. By Company, Middle East & Asia Eukaryotic Transcriptome Sequencing Market Share, 2019-2024
Figure 58. By Type, Middle East & Asia Eukaryotic Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 59. By Application, Middle East & Asia Eukaryotic Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 60. Research Methodology
Figure 61. Breakdown of Primary Interviews
Figure 62. Bottom-up Approaches
Figure 63. Top-down Approaches
Research Methodology:
Eukaryotic Transcriptome Sequencing Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|
Frequently asked questions(FAQ's):
A PHP Error was encountered
Severity: Warning
Message: Undefined variable $popupContent
Filename: report/singleReport.php
Line Number: 469
Backtrace:
File: /home/marke391/public_html/application/views/report/singleReport.php
Line: 469
Function: _error_handler
File: /home/marke391/public_html/application/controllers/Report.php
Line: 704
Function: view
File: /home/marke391/public_html/index.php
Line: 316
Function: require_once